Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
AudioTelligence delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems.
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Z Factor Limited is a drug discovery company to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency
Jukedeck is developing an artificially intelligent music composer.
Cambridge Innovation Capital has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cambridge Innovation Capital's top investment sectors include Biotechnology, Therapeutics, Audio, Software, Health Care. The firm invests across 10 different industry categories.
Among tracked funding rounds, Z Factor received $9.0M in a Series A round. Cambridge Innovation Capital's total known invested capital is $1.2B.
Cambridge Innovation Capital's average investment size is $28.9M across its portfolio of 52 companies.
Recent Cambridge Innovation Capital portfolio additions include AudioTelligence, PolyProx. These companies were founded in 2020 or later.